Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
You may give other people a serious infection, or get a serious infection from them
Metabolites have shorter detection windows of approximately 12 hours
10.1371/journal.pone.0044789 PLoS One 18 JiG.LvK.ChenH.WangT.WangY.ZhaoD.et al (2013)
What sets Direct Meds apart is its all-in-one model
10.15252/emmm.202216525 156
C5 inhibitor treatment complement inhibitor treatment Side effects (5%) in patients treated with EMPAVELI in the PEGASUS study vs eculizumab The following reactions were mild or moderate in severity: diarrhea, fatigue, fever, viral infections, and injection site reactions Serious adverse reactions were reported in 17% of patients treated with EMPAVELI The most common serious adverse reaction was infections (5%) Breakthrough hemolysis occurred in 10% of those taking EMPAVELI vs 23% of those taking eculizumab at Week 16 in the PEGASUS study
US$ 29.39
US$ 20.60
US$ 28.46
US$ 20.47
